ChiNext announced the formal signing of a lease with Hines and initiation of construction on its new Center for Bioprocessing (C4B) at its Levit Green facility in Houston, Texas USA.   Headquartered in Beijing, China with subsidiaries in Suzhou, China; Taizhou, China; Frankfurt, Germany; Kawasaki, Japan; and Wayne, Pennsylvania and listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), Sino Biological is the world's leading provider of mammalian cell-based recombinant proteins, antibodies, and related contract research services.  This new site serves as the company's first US-based manufacturing facility.  Referred to as the Center for Bioprocessing (C4B), the facility will focus on both product manufacture and the implementation of contract research services.  Levit Green will further establish its presence in Houston, providing companies, academics, and medical researchers in the world-renowned Texas Medical Center and across the region invaluable access to Sino Biological's comprehensive offering of bioreagents and CRO services.